These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1542731)

  • 1. [Recent progress of cancer immunology and its problems].
    Hashimoto Y
    Tanpakushitsu Kakusan Koso; 1992 Jan; 37(1):10-7. PubMed ID: 1542731
    [No Abstract]   [Full Text] [Related]  

  • 2. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
    Jäger E; Jäger D; Knuth A
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
    [No Abstract]   [Full Text] [Related]  

  • 3. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems of tumor immunology and immunotherapy].
    Schmidt CG
    Helv Chir Acta; 1973 Mar; 40(1):77-86. PubMed ID: 4540691
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in human tumour immunology and immunotherapy.
    Rosenberg SA
    Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor immunity and immunotherapy.
    Boura P; Kountouras J; Lygidakis NJ
    Hepatogastroenterology; 2001; 48(40):1040-4. PubMed ID: 11490795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular bases of cancer immunology].
    Barrera-Rodríguez R; Peralta-Zaragoza O; Madrid-Marina V
    Salud Publica Mex; 1995; 37(4):344-53. PubMed ID: 7502157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 10. [A model for colon cancer immunology and immunotherapy: the PRO/REG cell variants].
    Martin F; Martin M
    Gastroenterol Clin Biol; 2000 Oct; 24(10):923-8. PubMed ID: 11084430
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancer immunotherapy: immunologic bases, reality and hopes].
    Dietrich PY; Farace F; Caignard A; Escudier B; Triebel F
    Bull Cancer; 1993 Jul; 80(7):584-600. PubMed ID: 8204939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current aspects of tumor immunology. Preface and introduction.
    Weiss DW
    Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunology in tumor therapeutics: an overview.
    Barber HR
    Del Med J; 1980 Apr; 52(4):197-209. PubMed ID: 6153996
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunology: new approaches to immuno-modulation and immunotherapy].
    Kabelitz D
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer vaccine development: on the way to break immune tolerance to malignant cells.
    Mocellin S; Rossi CR; Nitti D
    Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of immune processes on the growth and regression of malignant tumors].
    Russo V; Russo L
    Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making and circumventing tolerance to cancer.
    Kammertoens T; Blankenstein T
    Eur J Immunol; 2009 Sep; 39(9):2345-53. PubMed ID: 19634191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.